Clinical Study of Single Incision Laparoscopic Cholecystectomy in the Treatment of Patients With Acute Cholecystitis

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Oct 5, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new method called Single Incision Laparoscopic Cholecystectomy (SILC) to treat patients with acute cholecystitis, which is an inflammation of the gallbladder often caused by gallstones. The goal is to see how this minimally invasive surgery affects patients' recovery, including their quality of life, level of pain, and any scarring or complications after the surgery. Currently, most patients undergo traditional laparoscopic surgery, which uses multiple small cuts, but SILC uses just one incision, potentially leading to less pain and better recovery.

To be eligible for the trial, participants should be between the ages of 18 and 75 and diagnosed with Grade I or II acute cholecystitis. However, those with severe liver disease, previous upper abdominal surgeries, or other significant complications from gallbladder issues may not qualify. Those who join the study can expect to receive the SILC procedure and be monitored for their recovery and any side effects, helping to advance knowledge about this surgical approach. This trial is important as it aims to create standardized procedures for SILC in treating acute cholecystitis, potentially improving outcomes for many patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Acute cholecystitis（GradeⅠ，II）
• Exclusion Criteria:
• • Combined with liver cirrhosis (Child grade B and above)
• • Upper abdominal surgical history;
• • Changes in surgical plan (conversion to laparotomy,cholangiography, bile duct exploration, bile duct injury repair, abscess clearance, multivisceral resection.)
• • Patients and their families do not agree with the treatment lost follow-up